… In newly diagnosed hemodialysis (HD) patients, the prevalence of LVH is 75%. Objective:
The aim of the current study is to detect early markers for LVH in HD patients. Patients and …

… copeptin level and volume status in hemodialysis patients. … , by the use of copeptin, in
ESKD patients. This study aimed to … copeptin level and volume status in hemodialysis patients. …

… The present meta-analysis showed that elevated copeptin plasma concentrations observed
in HF patients are associated with an increased risk of all-cause mortality, thus copeptin may …

… group had significantly higher osmolarity and worse renal function than the low-copeptin group
(… Comparison of neuroendocrine activation in patients with left ventricular dysfunction with …

… Elevated levels of serum copeptin in both cardiovascular and renal diseases were known …
patient groups trigger left ventricular wall stress and increase serum vasopressin and copeptin …

… decreased copeptin clearance and impaired renal function. … In addition, for patients with
HF, copeptin has been proposed … Copeptin was reported to be associated with left ventricular …

… term outcomes in HD patients. For example, in HD patients with T2DM, copeptin was positively
… targeted therapy against AVP receptors in HD patients. Further studies are needed to find …

… Brain natriuretic peptide (BNP) is mainly released from the left ventricle of a diseased heart
… Further, in patients with CKD including those on hemodialysis, Copeptin levels were shown …

… function decline in the general population. Our aim was to study the links between elevated
copeptin … Baseline copeptin was related to risk of development of renal disease using …

… , this contributes to left ventricular remodelling and failure. Copeptin is released in equimolar
… They concluded that renal impairment was prevalent in patients with HF and high plasma …